BioTrinity 2010 programme covers two full days and includes a hand-picked company presentations from the UK's best biotech and medtech companies; pharma and investor panel discussions covering the choices for financing and exits for biotech companies, whether that be VC/equity financing, licensing deals or pharma acquisition; and, interactive workshops to update you on the latest industry trends and advice.
The Preliminary Programme is now available to view.
If your company is not presenting but you feel you would like to be included in the programme, contact Jon Rees for more information.
More detail about the agenda:
In 2010, we have substantially increased the amount of networking space by creating additional networking hubs, and we have also created an entertaining social programme to further increase the opportunities for networking.